Follicle-stimulating ho上頻rmone (FSH) is a 都子glycoprotein ho外又rmone secreted by bas著麗ophils in the ant請相erior pituitary gland, which can p做了romote the prolife吧哥ration and differentiation of gr校自anulosa cells in th山員e follicle, the 有場maturation of the folli什章cle, and the growth of the entire 時廠ovary. It also helps 森朋to promote sperm formation; and to prom訊電ote estrogen secretion together w計銀ith luteinizing hormone.

FSH is mainly us音件ed for: 1. Women who do n在見ot ovulate (including polycys海電tic ovary syndrome [PCOD]) and笑區 do not respond to clomiphene citrate女窗 treatment. 2. For patients undergoing學厭 superovulation or assisted fertility技那 techniques such as in長我 vitro fertilization-embryo快一 transfer (IVF), ga兒窗mete intrafallopian tube transfer (GIFT秒到), and zygote intrafallop術兵ian tube transfer (ZIFT).間低

The domestic market of follicle 分說stimulating hormone has exceeded 2 bil河光lion RMB, and the main market is th腦暗e imported produ下會ct Guonafen. GenSci's reco哥票mbinant human follicle海照 stimulating hormone is t從能he first domestically produc森窗ed genetic recombination product on th件家e market. At present, the nu秒用mber of people who have not adopted an妹拿y contraceptive measu相弟res for more than o身水ne year in China is 2.1 mil技銀lion. The number o音快f infertile people w市湖ill continue to expand wit雨樂h the delay of the marriage and child做海bearing age and the deter煙日ioration of the living e白章nvironment, there討兵by the market will continue to expand雜會. As an important p水樂roduct in the field of assist議生ed reproduction, the future marke窗我t of follicle stimulati上外ng hormone is huge.

In 2018 (company?), the sales re他廠venue of recombi去門nant follicle-st門好imulating hormone reached 135 millio紙你n RMB, accounting for about 7% of 山為the domestic market.